These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33021983)

  • 1. Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation.
    Hill EM; Petrou S; Forster H; de Lusignan S; Yonova I; Keeling MJ
    PLoS Comput Biol; 2020 Oct; 16(10):e1008278. PubMed ID: 33021983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.
    Baguelin M; Camacho A; Flasche S; Edmunds WJ
    BMC Med; 2015 Oct; 13():236. PubMed ID: 26459265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
    Thorrington D; van Leeuwen E; Ramsay M; Pebody R; Baguelin M
    Vaccine; 2019 Apr; 37(15):2051-2056. PubMed ID: 30871927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health and economic impact of the seasonal influenza vaccination programme in England.
    Baguelin M; Jit M; Miller E; Edmunds WJ
    Vaccine; 2012 May; 30(23):3459-62. PubMed ID: 22446636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model.
    Pitman RJ; Nagy LD; Sculpher MJ
    Vaccine; 2013 Jan; 31(6):927-42. PubMed ID: 23246550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England.
    Thorrington D; van Leeuwen E; Ramsay M; Pebody R; Baguelin M
    BMC Med; 2017 Sep; 15(1):166. PubMed ID: 28882149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
    Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
    Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
    Lugnér AK; van Boven M; de Vries R; Postma MJ; Wallinga J
    BMJ; 2012 Jul; 345():e4445. PubMed ID: 22791791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
    Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
    JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted vaccination in healthy school children - Can primary school vaccination alone control influenza?
    Thorrington D; Jit M; Eames K
    Vaccine; 2015 Oct; 33(41):5415-5424. PubMed ID: 26314627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives.
    de Fougerolles TR; Baïssas T; Perquier G; Vitoux O; Crépey P; Bartelt-Hofer J; Bricout H; Petitjean A
    BMC Public Health; 2024 May; 24(1):1222. PubMed ID: 38702667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1555-1576. PubMed ID: 33297613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
    Brogan AJ; Talbird SE; Davis AE; Thommes EW; Meier G
    Hum Vaccin Immunother; 2017 Mar; 13(3):533-542. PubMed ID: 27780425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
    Baguelin M; Hoek AJ; Jit M; Flasche S; White PJ; Edmunds WJ
    Vaccine; 2010 Mar; 28(12):2370-84. PubMed ID: 20096762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the optimal target age group for seasonal influenza vaccination in Japan.
    Tsuzuki S; Baguelin M; Pebody R; van Leeuwen E
    Vaccine; 2020 Jan; 38(4):752-762. PubMed ID: 31735503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling.
    Dawa J; Emukule GO; Barasa E; Widdowson MA; Anzala O; van Leeuwen E; Baguelin M; Chaves SS; Eggo RM
    BMC Med; 2020 Aug; 18(1):223. PubMed ID: 32814581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis.
    Sandmann FG; van Leeuwen E; Bernard-Stoecklin S; Casado I; Castilla J; Domegan L; Gherasim A; Hooiveld M; Kislaya I; Larrauri A; Levy-Bruhl D; Machado A; Marques DFP; Martínez-Baz I; Mazagatos C; McMenamin J; Meijer A; Murray JLK; Nunes B; O'Donnell J; Reynolds A; Thorrington D; Pebody R; Baguelin M
    Vaccine; 2022 Feb; 40(9):1306-1315. PubMed ID: 35109968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
    Thommes EW; Ismaila A; Chit A; Meier G; Bauch CT
    BMC Infect Dis; 2015 Oct; 15():465. PubMed ID: 26503131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health and economic benefits of new pediatric influenza vaccination programs in Argentina.
    Giglio N; Gentile A; Lees L; Micone P; Armoni J; Reygrobellet C; Crépey P
    Hum Vaccin Immunother; 2012 Mar; 8(3):312-22. PubMed ID: 22330959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.